This study will evaluate any effect of single and repeated administration of GW876008 on the metabolism of midazolam in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
25
GSK Investigational Site
Dallas, Texas, United States
Blood levels of GW876008 and midazolam collected on Day 1 of Session 1 and on Days 1 and 14 of Session 2.
Time frame: on Day 1 of Session 1 and on Days 1 and 14 of Session 2.
12-lead ECG, Continuous Lead II Telemetry & adverse events: day 1 session 1; days 1 & 14 session 2
Time frame: day 1 session 1; days 1 & 14 session 2
vital signs & clinical laboratory data: day 1 session 1; days 1, 7 & 14 session 2
Time frame: day 1 session 1; days 1, 7 & 14 session 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.